Cart
sales@molnova.com
Procyanidin A1
CAS No. 103883-03-0
Procyanidin A1( Proanthocyanidin A1 )
Catalog No. M23247 CAS No. 103883-03-0
Procyanidin A1 has antiallergic effects, it inhibits degranulation downstream of protein kinase C activation or Ca2+; influx from an internal store in RBL-2H3 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 424 | In Stock |
|
| 50MG | 600 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProcyanidin A1
-
NoteResearch use only, not for human use.
-
Brief DescriptionProcyanidin A1 has antiallergic effects, it inhibits degranulation downstream of protein kinase C activation or Ca2+; influx from an internal store in RBL-2H3 cells.
-
DescriptionProcyanidin A1 has antiallergic effects, it inhibits degranulation downstream of protein kinase C activation or Ca2+; influx from an internal store in RBL-2H3 cells.
-
In Vitro——
-
In Vivo——
-
SynonymsProanthocyanidin A1
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel|LDL|PKC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number103883-03-0
-
Formula Weight576.5
-
Molecular FormulaC30H24O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (173.46 mM)
-
SMILESO[C@@H](C1)[C@@H](c(cc2)cc(O)c2O)Oc2c1c(O)cc1c2[C@H]([C@@H]2O)c(c(O)cc(O)c3)c3O[C@@]2(c(cc2)cc(O)c2O)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Effects of peanut-skin procyanidin A1 on degranulation of RBL-2H3 cells.Biosci Biotechnol Biochem. 2011;75(9):1644-8.
molnova catalog
related products
-
Coptisine sulfate
Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program.
-
GSK-7975A
A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.
-
Diltiazem
Diltiazem (CRD 401 free base) is an orally available L-type Ca2+ channel blocker with antihypertensive, antiarrhythmic, and cardioprotective properties that prevent post-reperfusion myocardial injury, angina pectoris, and cardiovascular-related diseases.
